BEAM
Price
$24.95
Change
+$0.28 (+1.13%)
Updated
Sep 18 closing price
Capitalization
2.58B
50 days until earnings call
Intraday BUY SELL Signals
VIR
Price
$10.60
Change
-$0.32 (-2.93%)
Updated
Sep 18 closing price
Capitalization
1.79B
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs VIR

BEAM vs VIR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. VIR commentary
Sep 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and VIR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.58B) has a higher market cap than VIR($1.79B). VIR YTD gains are higher at: 75.788 vs. BEAM (-9.993). VIR has higher annual earnings (EBITDA): -268.68M vs. BEAM (-355.78M). BEAM has more cash in the bank: 1.15B vs. VIR (533M). VIR has less debt than BEAM: VIR (93.3M) vs BEAM (247M). VIR has higher revenues than BEAM: VIR (303M) vs BEAM (156M).
BEAMVIRBEAM / VIR
Capitalization2.58B1.79B144%
EBITDA-355.78M-268.68M132%
Gain YTD-9.99375.788-13%
P/E RatioN/A6.40-
Revenue156M303M51%
Total Cash1.15B533M216%
Total Debt247M93.3M265%
FUNDAMENTALS RATINGS
BEAM vs VIR: Fundamental Ratings
BEAM
VIR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9296
PRICE GROWTH RATING
1..100
6338
P/E GROWTH RATING
1..100
10023
SEASONALITY SCORE
1..100
5038

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BEAM's Valuation (25) in the null industry is in the same range as VIR (57). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

BEAM's Profit vs Risk Rating (100) in the null industry is in the same range as VIR (100). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

BEAM's SMR Rating (92) in the null industry is in the same range as VIR (96). This means that BEAM’s stock grew similarly to VIR’s over the last 12 months.

VIR's Price Growth Rating (38) in the null industry is in the same range as BEAM (63). This means that VIR’s stock grew similarly to BEAM’s over the last 12 months.

VIR's P/E Growth Rating (23) in the null industry is significantly better than the same rating for BEAM (100). This means that VIR’s stock grew significantly faster than BEAM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BEAMVIR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
66%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
77%
Aroon
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
72%
COMPARISON
Comparison
Sep 20, 2026
Stock price -- (BEAM: $24.95 vs. VIR: $10.60)
Brand notoriety: BEAM and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 140% vs. VIR: 517%
Market capitalization -- BEAM: $2.58B vs. VIR: $1.79B
BEAM [@Biotechnology] is valued at $2.58B. VIR’s [@Biotechnology] market capitalization is $1.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $128.84B. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green while VIR’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 1 green, 4 red.
According to our system of comparison, VIR is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while VIR’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 6 bearish.
  • VIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, VIR is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +4.00% price change this week, while VIR (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.53%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +7.13%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

VIR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (+1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
VIR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FPX179.461.73
+0.97%
First Trust US Equity Opportunities ETF (FPX)
AVUQ67.030.36
+0.54%
Avantis U.S. Quality ETF Shs Avantis US Growth Equity ETF (AVUQ)
ESBG21.470.05
+0.25%
First Trust Enhanced Stocks, Bonds & Gold ETF (ESBG)
BTOT47.95N/A
N/A
iShares Total USD Fixed Income Market ETF (BTOT)
EVF4.85-0.01
-0.21%
Eaton Vance Senior Income Trust

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.13%
CRSP - BEAM
77%
Closely correlated
-1.33%
EDIT - BEAM
66%
Closely correlated
-0.74%
PRME - BEAM
66%
Loosely correlated
-0.64%
NTLA - BEAM
61%
Loosely correlated
-0.98%
RXRX - BEAM
59%
Loosely correlated
+8.19%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
-2.93%
BEAM - VIR
54%
Loosely correlated
+1.13%
DNLI - VIR
52%
Loosely correlated
-2.04%
EDIT - VIR
51%
Loosely correlated
-0.74%
RCUS - VIR
50%
Loosely correlated
-1.17%
CRBU - VIR
49%
Loosely correlated
-0.76%
More